News
2d
Zacks.com on MSNShould You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Pharmacy chain BENU is warning that a steep price increase for the blood thinner Eliquis is threatening patient access to ...
A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit ...
I recently read a letter published in your paper in which a concerned citizen called on the government and insurance companies to negotiate better drug prices, citing the high cost of medication in ...
EXCLUSIVE: Millions of Australians with severe pain, asthma or menopause will be the big winners under Labor’s plan to slash ...
AstraZeneca’s top medical executive Cristian Massacesi will replace Bristol Myers’ current chief medical officer, Samit ...
Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...
Bristol-Myers Squibb Co.’s chief medical officer is stepping down from his role after six years at the company, a surprise ...
6d
Zacks Investment Research on MSNBristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?
Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
Pharmaceutical companies have been in talks with the U.S. government to figure out how to bring drug prices down after President Trump signed in May an executive order that ties U.S. prices to the ...
2d
24/7 Wall St. on MSN4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential
Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
In July 2025, Medtronic Cardiac Rhythm and Heart Failure conducted a study is to demonstrate the efficiency on AT / AF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results